Overexpression of both RAR and RXR restores AP-1 repression in ovarian adenocarcinoma cells resistant to retinoic acid-dependent growth inhibition.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Oncogene

• Publication date

  1996-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8637715
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppression of collagenase gene expression by all‐trans and 9‐cis retinoic acid is ligand dependent and requires both RARs and RXRs

  1995cited by this paper
• RAR‐specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage‐independent cell proliferation.

  1995cited by this paper
• Separation of Transactivation and AP1 Antagonism Functions of Retinoic Acid Receptor (*)

  1995cited by this paper
• Response of four human ovarian carcinoma cell lines to ALL‐TRANS retinoic acid: Relationship with induction of differentiation and retinoic acid receptor expression

  1994cited by this paper
• Genetic instability in human ovarian cancer cell lines.

  1994cited by this paper
• A new class of retinoids with selective inhibition of AP-1 inhibits proliferation

  1994cited by this paper
• Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity.

  1993cited by this paper
• Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex.

  1993cited by this paper
• Retinoic acid receptors in retinoid responsive ovarian cancer cell lines detected by polymerase chain reaction following reverse transcription.

  1993cited by this paper
• Normal development and growth of mice carrying a targeted disruption of the alpha 1 retinoic acid receptor gene.

  1993cited by this paper
• High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice.

  1993cited by this paper
• Nuclear receptor/AP-1 interaction.

  1993cited by this paper
• Function of retinoic acid receptor gamma in the mouse.

  1993cited by this paper
• 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα

  1992cited by this paper
• Retinoids in cancer therapy.

  1992cited by this paper
• Differential regulation of collagenase gene expression by retinoic acid receptors--alpha, beta and gamma.

  1992cited by this paper
• 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor.

  1992cited by this paper
• A sensitive method for the detection of beta-galactosidase in transfected mammalian cells.

  1991cited by this paper
• The effects of dimethyl sulfoxide and retinoic acid on the cell growth and the phenotype of ovarian cancer cells.

  1991cited by this paper
• Retinoic acid is a negative regulator of AP-1-responsive genes.

  1991cited by this paper
• The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.

  1991cited by this paper
• A potential role for c-jun in cell cycle progression through late G1 and S.

  1991cited by this paper
• Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.

  1990cited by this paper
• Effects of biological response modifiers on ovarian carcinoma cell lines.

  1989cited by this paper
• A simple phase-extraction assay for chloramphenicol acyltransferase activity.

  1988cited by this paper
• Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.

  1988cited by this paper
• Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines.

  1988cited by this paper
• Time of c-fos and c-myc expression in human diploid fibroblasts stimulated to proliferate after prolonged periods in quiescence.

  1987cited by this paper

• CD437 induces apoptosis in ovarian adenocarcinoma cells via ER stress signaling.

  2008cites this paper
• 4‐HPR modulates gene expression in ovarian cells

  2006cites this paper
• Action of fenretinide (4-HPR) on ovarian cancer and endothelial cells.

  2005cites this paper
• Retinoic acid induced repression of AP‐1 activity is mediated by protein phosphatase 2A in ovarian carcinoma cells

  2005cites this paper
• A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma.

  2004cites this paper
• Retinoic acid receptors and cancers.

  2004cites this paper
• Pre-B Cell Leukemia Transcription Factor (PBX) Proteins Are Important Mediators for Retinoic Acid-dependent Endodermal and Neuronal Differentiation of Mouse Embryonal Carcinoma P19 Cells*

  2004cites this paper
• Cell Cycle Regulatory Genes as Targets of Retinoids

  2003cites this paper
• Immunohistochemical localization of the retinoic Acid receptors in human prostate.

  2002cites this paper
• Regulation of Retinoic Acid-induced Inhibition of AP-1 Activity by Orphan Receptor Chicken Ovalbumin Upstream Promoter-Transcription Factor*

  2002cites this paper
• Unique property of some synthetic retinoids: activation of the aryl hydrocarbon receptor pathway.

  2002cites this paper
• Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma.

  2001cites this paper
• Disassociation of MAPK Activation and c-Fos Expression in F9 Embryonic Carcinoma Cells following Retinoic Acid-induced Endoderm Differentiation*

  2001cites this paper
• Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis.

  2001cites this paper
• Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.

  2001cites this paper
• Disabled-2 Mediates c-Fos Suppression and the Cell Growth Regulatory Activity of Retinoic Acid in Embryonic Carcinoma Cells*

  2001cites this paper
• Increased Retinoic Acid Responsiveness in Lung Carcinoma Cells that Are Nonresponsive Despite the Presence of Endogenous Retinoic Acid Receptor (RAR) β by Expression of Exogenous Retinoid Receptors Retinoid X Receptor α, RARα, and RARγ

  2001cites this paper
• Mechanism of inhibition on activator protein-1 activity by all-trans retinoic acid in gastric cancer cells.

  2000cites this paper
• Murine RARβ4 displays reduced transactivation activity, lower affinity for retinoic acid, and no anti‐AP1 activity

  2000cites this paper
• Loss of growth inhibitory effects of retinoic acid in human breast cancer cells following long-term exposure to retinoic acid

  2000influential citation
• Responsive site on the thrombospondin-1 promotor to down-regulation by phorbol 12-myristate 13-acetate in porcine aortic endothelial cells

  2000cites this paper
• Retinoids and ovarian cancer

  2000cites this paper
• Induction of apoptosis in ovarian carcinoma cells by AHPN/CD437 is mediated by retinoic acid receptors

  2000cites this paper
• Overexpression of insulin‐like growth factor II (IGFII) in ZR‐75‐1 human breast cancer cells: higher threshold levels of receptor (IGFIR) are required for a proliferative response than for effects on specific gene expression

  1999cites this paper
• Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid

  1998cites this paper
• Promotion‐sensitive epidermal and mammary epithelial cells maintained in suspension over agarose

  1998cites this paper
• Effects of conformationally restricted synthetic retinoids on ovarian tumor cell growth

  1998cites this paper
• Interactions with Single-stranded and Double-stranded DNA-binding Factors and Alternative Promoter Conformation upon Transcriptional Activation of the Htf9-a/RanBP1 andHtf9-c Genes*

  1998cites this paper
• Cellular distribution of retinoic acid receptor-alpha protein in serous adenocarcinomas of ovarian, tubal, and peritoneal origin: comparison with estrogen receptor status.

  1998cites this paper
• The v-erbA Oncogene

  1997cites this paper
• All-trans-retinoic acid blocks cell cycle progression of human ovarian adenocarcinoma cells at late G1.

  1997cites this paper
• Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation

  1997cites this paper
• Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.

  1997cites this paper
• Reduction of both RAR and RXR levels is required to maximally alter sensitivity of CA-OV3 ovarian tumor cells to growth suppression by all-trans-retinoic acid.

  1997cites this paper
• Stable transfection of U937 cells with sense or antisense RXR-alpha cDNA suggests a role for RXR-alpha in the control of monoblastic differentiation induced by retinoic acid and vitamin D.

  1997cites this paper
• Molecular Mechanisms of Retinoid Function

  1997cites this paper
• Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.

  1997cites this paper
• Number DAMD 1794-J-4440 TITLE : Mechanism of Retinoid Response in Human Breast Cancer

  year unknowncites this paper